Table 1 Demographic details of Aortic Stenosis and haemodialysis patients
From: Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance
Variable | Aortic Stenosis patients (areas of discrete signal increase on native T1) (n = 25) | Haemodialysis patients areas of discrete signal increase on native T1) (n = 25) | Haemodialysis patients (no areas of discrete signal increase on native T1) (n = 19) |
|---|---|---|---|
Age (years) | 66.9 ± 13.7 | 58.1 ± 16.5 | 49.9 ± 16.9 |
Male (n, %) | 18 (72) | 18 (72) | 16 (84) |
BMI (kg/m2) | 29.4 ± 4.4 | 27.8 ± 6.8 | 27.9 ± 6.4 |
Dialysis Vintage (months) | – | 35.4 ± 25.8 | 26.9 ± 21.6 |
Haemoglobin (g/L) | 14.5 ± 1.2 | 11.4 ± 1.6 | 10.4 ± 1.6 |
HbA1c (%) | 5.9 ± 0.9 | 5.4 ± 1.8 | 5.4 ± 0.6 |
SBP (mmHg) | 158.8 ± 21.4 | 152.6 ± 22.5 | 127.6 ± 25.8 |
DBP (mmHg) | 78.3 ± 9.6 | 79.5 ± 10.5 | 72.5 ± 19.1 |
HR (bpm) | 70.1 ± 10 | 72.8 ± 12.5 | 78.1 ± 11.1 |
Past medical and drug history | |||
 Hypertension (n, %) | 18 (72) | 21 (84) | 11 (58) |
 Diabetes (n, %) | 4 (16) | 7 (28) | 4 (21) |
 CAD (n, %) | 11 (44) | 9 (36) | 4 (21) |
 Prev MI (n, %) | 3 (12) | 5 (20) | 1 (5) |
 ACEi (n, %) | 7 (28) | 2 (8) | 1 (5) |
 ARB (n, %) | 4 (16) | 3 (12) | 1 (5) |
 Diuretic (n, %) | 7 (28) | 3 (12) | 4 (21) |
 Beta Blocker (n, %) | 10 (40) | 12 (48) | 6 (32) |
 Statin (n, %) | 17 (68) | 14 (56) | 5 (26) |
 Calcium Channel Blocker (n, %) | 11 (44) | 11 (44) | 5 (26) |
 Number of antihypertensives | 1.6 ± 1.2 | 1.4 ± 0.9 | 1.3 ± 1.1 |
Left Ventricular mass and volumes (CMR) | |||
 LVEDV (ml) | 190.3 ± 43.4 | 198.8 ± 54.3 | 160.1 ± 48 |
 LVEF (%) | 56.5 ± 6.5 | 52.2 ± 6.4 | 50.5 ± 6.2 |
 LVM (g) | 135.4 ± 42.4 | 116.1 ± 29.4 | 104.1 ± 45.3 |
 LVM/LVEDV (g/ml) | 0.71 ± 0.1 | 0.59 ± 0.1 | 0.62 ± 0.1 |